Skip To Main Content
Jennifer Rauch on Muck Rack

Jennifer Rauch

Portland
As seen in: Medium, HuffPost, OUPblog, Taylor & Francis Online, Science Magazine, Routledge, Thrive Global, The Journal of Biological Chemistry
I am not using this platform now. Find me at linkedin.com/in/jlrauch, Linfield.edu/faculty/jrauch2.html, or jennifer-rauch.com/contact

Get in touch with Jennifer

Contact Jennifer, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

The Contexts and Consequences of Hybridity for Alternative News Audiences

|
By Jennifer Rauch
| Taylor & Francis Online
This commentary surveys and analyzes the flourishing field of alternative news audiences, whose values, attitudes and practices were previously underexamined by scholarship. Rauch discusses this new research as a response to significant recent shifts in the conceptualization of both audiences and alternative news, including recognition of their hybridity as well as their negative influences on democratic discourse.
Open in Who Shared Issue with article?

Resisting the News

|
By Jennifer Rauch
| Routledge Verified
Resisting the News: Engaged Audiences, Alternative Media, and Popular Critique of Journalism ISBN | Quantity: Shopping Cart Summary Items: Routledge & CRC Press eBooks are available through VitalSource. The free VitalSource Bookshelf® application allows you to access to your eBooks whenever and wherever you choose. Mobile/eReaders – Download the Bookshelf mobile app at VitalSource.com or from the iTunes or Android store to access your eBooks from your mobile device or eReader.
Open in Who Shared Issue with article?

A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy

|
By Israel Hernández Tabernero, Gabriel Luna, Jennifer Rauch
| Science Magazine Verified
Tau inclusions are a prominent feature of many neurodegenerative diseases and are considered to be a potential therapeutic target. Hernandez et al. now report a previously unrecognized pathway leading to tau clearance via the lysosome. Activation of this pathway by inhibiting the enzyme farnesyltransferase blocks the attachment of a neuronal protein, Rhes, to the cell membrane. Farnesyltransferase inhibitors are already in use in human patients for treating cancer.
Open in Who Shared Issue with article?
See all 8 licensed articles (9 Total)